Advertisement
Home »

Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman’s disease types: Implications for the mTOR signaling pathway.

Oct 02, 2023

ABOUT THE EXPERTS

  • Remi Sumiyoshi

    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Clincal Research Center, Nagasaki University Hospital, Nagasaki, Japan.

    Tomohiro Koga

    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Electronic address: tkoga@nagasaki-u.ac.jp.

    Shoichi Fukui

    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

    Kaori Furukawa

    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

    Mamiko Momoki

    Division of Clinical Oncology & Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.

    Kunihiro Ichinose

    Department of Rheumatology, Shimane University Faculty of Medicine, Izumo, Japan.

    Shingo Yano

    Division of Clinical Oncology & Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

    Atsushi Kawakami

    Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement